Analyst Ratings for Akebia Therapeutics (AKBA) [Sells]
AKBA Rating Summary
AKBA Price Target Summary
- Highest: $6.00 (H.C. Wainwright)
- Lowest: $4.00 (BTIG)
- Average: $4.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$4.67 (+250.9%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
Avg. $ Target:
$4.67 (+250.9%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 69%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2021 | JPMorgan | Eric Joseph | Downgrade | Underweight (Neutral) |
N/A (N/A) |
3.49 (1.33) |
-61.89% | Details |
